Atlas Trials

Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients

Clinical trial NCT06265259 · UNKNOWN

Trial details

NCT number
NCT06265259
Sponsor
University of Thessaly
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Circulatory Shock
Start date
2023-12-15
Primary completion
2025-12-31
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.